( Bloomberg:RHHBY@US, Bloomberg:RO@SW, Bloomberg:ROG@VX, RICS:RHHBY, RICS:RO.S, RICS:ROG )

News from Roche Molecular Systems, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 03, 2017, 08:00 ET Roche to initiate testing for Babesia parasite at U.S. Blood Centers under FDA Investigational New Drug Application protocol

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced immediate plans to initiate screening of blood samples with the cobas® Babesia test under an...


Jul 02, 2012, 09:00 ET Roche announces FDA approval of HIV viral load test

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a new HIV viral load test has been approved by the United States Food and Drug...


Jul 25, 2011, 12:57 ET KRAS-Diagnosetest als Hilfsmittel bei personalisierter Behandlung von Kolorektalkarzinom erhält CE-Zeichen

- cobas KRAS Mutation Test erkennt Kolorektalkarzinom-Patienten, die aller Voraussicht nach nicht auf eine Anti-EGFR-Antikörpertherapie...


Jul 24, 2011, 01:17 ET Le test diagnostic KRAS utilisé dans le traitement personnalisé du cancer colorectal obtient la marque CE

Le test de mutation KRAS Cobas permet d'identifier les patients souffrant d'un cancer colorectal qui ne répondront probablement pas aux...


Jul 22, 2011, 13:36 ET El test de diagnosis KRAS recibe la Marca CE

- El test de diagnosis KRAS, que ayuda con un tratamiento personalizado en casos de cáncer colorrectal, recibe la Marca CE - El cobas KRAS...


Jul 22, 2011, 01:00 ET KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas KRAS Mutation Test is now commercially available in Europe for use in colorectal...


Oct 11, 2010, 02:00 ET Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the German Cancer Research Center (DKFZ) announced today that they have entered into...


Jul 08, 2010, 16:25 ET FDA Clears Roche's LightCycler(R) MRSA Advanced Test for Use in the U.S.

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) cleared its new...


Feb 18, 2010, 04:00 ET Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced...


Feb 17, 2010, 12:00 ET Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation

Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today a research collaboration with Merck Sharp & Dohme Corp. (a...


Dec 02, 2009, 06:00 ET FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food & Drug Administration (FDA) approved an additional intended...